The Volume Inflection Lands: Frito-Lay Turns Positive, Organic Revenue Accelerates to +2.6%, Core EPS Grows 9% and FY26 Guidance Holds — But the Turn Is Now Priced. Maintain Outperform
Key Takeaways
- The variable the upgrade was gated on turned positive. PepsiCo Foods North America (Frito-Lay) delivered organic volume growth — +2% volume, +4% unit growth, "300 million new occasions" versus Q1 2025 — the long-awaited inflection that the three-quarter Hold-to-Outperform arc was waiting on. Management called it "a notable improvement in convenient foods organic volume," and Beverages volume trends also improved sequentially and year-over-year. The turn is no longer a guided promise; it printed.
- Total results beat the Street cleanly: net revenue $19,443M (+8.5% reported, +2.6% organic, accelerating from Q4) versus ~$18.94B consensus, and core EPS $1.61 (+9%, +5% constant currency) versus ~$1.55 consensus. GAAP EPS of $1.70 (+27%) is flattered by an easy prior-year base — the operationally honest number is the +9% core / +5% constant-currency print, which is solid but not the double-digit growth Q4 delivered.
- International re-accelerated across the board — every international segment posted a sequential acceleration in net-revenue growth, with EMEA organic +7%, Asia Pacific Foods +7% (volume +10%), and IB Franchise +5%. Management reported "no impact on demand" from the Iran conflict and flagged FX as a ~3.4-point reported revenue tailwind and ~4-point operating-profit tailwind this quarter — the FX flip we underwrote in Q4 is fully in the numbers.
- FY2026 guidance was affirmed, not raised: organic revenue +2–4%, core constant-currency EPS +4–6%, plus the previously announced 4% dividend increase (54th consecutive year) beginning with the June 2026 payment and ~$8.9B of total cash returns. None of the Q4 downgrade triggers tripped — PFNA volume turned positive rather than re-accelerating down, and total-company core operating margin expanded (+10bp) rather than compressing on the affordability pricing.
- Rating: Maintaining Outperform. Q1 confirms the Q4 upgrade thesis on its own terms: the Foods volume turn is real, organic growth accelerated, margin held, International is durable, and the return-to-growth guide is intact. But we are honest about the changed setup — the stock entered the print +10.5% over twelve months, the muted +2.3% reaction (versus +4.9% at Q4) signals the recovery is substantially priced, and the asymmetry that made the washed-out July 2025 entry compelling has compressed. The Outperform now rests on continued execution of the turn — sustained PFNA volume, productivity funding growth, International durability, and Elliott optionality — not on a re-rating off a trough.
Results vs. Consensus
Q1 2026 Scorecard
| Metric | Q1 2026 Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Net Revenue | $19,443M | ~$18,940M | Beat | +$0.50B (+2.6%) |
| Organic Revenue Growth | +2.6% | ~+1.7–2% | Beat | ~+60–90bp |
| Gross Margin (reported) | 55.2% | ~55.5% (est.) | Slight Miss | −30bp vs. PY (55.8%) |
| Core Operating Margin | 15.7% | ~15.6% (est.) | In line / Beat | +10bp YoY |
| Core Operating Profit | $3,050M | ~$3,000M (est.) | Beat | +9% YoY |
| Core EPS | $1.61 | $1.55 | Beat | +$0.06 (+3.9%) |
| Core Constant-Currency EPS | +5% | — | Solid | vs. +4–6% FY guide |
| GAAP EPS | $1.70 | — | +27% YoY | flattered by PY base |
| Adjusted EBITDA | ~$3,792M | ~$3,692M | Beat | +~$100M (~+2.7%) |
Year-Over-Year Comparisons
| Metric | Q1 2026 | Q1 2025 | YoY Change |
|---|---|---|---|
| Net Revenue | $19,443M | $17,919M | +8.5% |
| Gross Profit | $10,731M | $9,993M | +7.4% |
| Gross Margin | 55.2% | 55.8% | −60bp |
| GAAP Operating Profit | $3,213M | $2,583M | +24% |
| GAAP Operating Margin | 16.5% | 14.4% | +210bp |
| Core Operating Profit | $3,050M | $2,789M | +9% |
| Core Operating Margin | 15.7% | 15.6% | +10bp |
| Core EPS | $1.61 | $1.48 | +9% |
| GAAP EPS | $1.70 | $1.33 | +27% |
Sequential Trajectory (vs. Q4 2025)
| Metric | Q4 2025 | Q1 2026 | Sequential Read |
|---|---|---|---|
| Organic revenue growth | ~+2.1% | +2.6% | Accelerating |
| PFNA volume | −1% | +2% | Turned positive |
| PBNA volume | −4% | −4% (~flat ex-water transition) | Improving underneath |
| Core EPS growth (c.c.) | +11% | +5% | Decelerated |
| FX | +2pt rev / +5pt EPS (turned tailwind) | +3.4pt rev / +4pt OP | Tailwind widened |
| FY guide | Affirmed +4–6% core c.c. EPS | Affirmed +4–6% core c.c. EPS | Unchanged |
Quality of Beat
Revenue: The reported +8.5% headline overstates the underlying business; the operationally relevant number is organic +2.6%, which accelerated from Q4's ~+2.1%. The bridge: +3.4pt of FX translation tailwind, +2.5pt net from acquisitions and divestitures (chiefly the poppi acquisition and beverage-platform additions in PBNA, partly offset by divestitures), and the +2.6% organic core. The most important sub-component is that organic growth was driven by effective net pricing plus a slight positive contribution from organic volume — the first time in the coverage arc that consolidated organic volume has not been a drag. Against ~$18.94B consensus, this is a ~$0.50B beat sourced from the right place.
Margins: Two stories diverge by line. Reported gross margin fell ~60bp to 55.2% as the affordability price investments (lower effective net pricing in PFNA, −1pt) and input costs compressed the gross line. But core operating margin still expanded 10bp to 15.7%, with core operating profit +9%. The reconciliation: productivity savings, net revenue growth, and a 4-point FX translation tailwind drove the operating line, partly offset by operating-cost increases and the lap of a prior-year PFNA property-sale gain. The 10bp of core OM expansion is modest — far below Q4's +140bp — but it is the proof point that matters: the affordability investments did not break the operating margin, which was the central Q4 downgrade trigger.
EPS: Core EPS $1.61 (+9%) beat by $0.06. The +9% breaks down as roughly +5% constant-currency operations plus a ~4-point FX tailwind. Below the operating line, the picture is mildly negative: net interest expense widened to $301M (from $264M), the core effective tax rate ticked up to 21.1% (from 20.4%), and the share count fell only fractionally. So the EPS beat is entirely operating-and-FX driven, with the below-the-line items a slight drag — a higher-quality composition than a tax-rate or buyback-flattered beat. The contrast with the headline GAAP +27% is instructive: the GAAP number benefits from a $1.86B-plus lighter restructuring/impairment load versus the prior-year Q1, and should be ignored in favor of the +9% core / +5% constant-currency figures.
Segment Performance
PepsiCo reports six operating segments — two North America (Foods and Beverages) and four international. The Q1 story is a clean read: North America is healing (Foods volume turned, Beverages improving underneath a one-time water-distribution transition), and International is the durable growth engine that re-accelerated everywhere.
| Segment | Net Revenue | Reported % | Organic % | Volume % | Core c.c. OP % | Read |
|---|---|---|---|---|---|---|
| PFNA (Frito-Lay NA) | $6,332M | +2% | +1% | +2% | −5% | Volume turn; margin invested |
| PBNA (Pepsi Bev. NA) | $6,391M | +9% | +2% | −4% | +7% | ~flat volume ex-water; profit re-expanding |
| IB Franchise | $824M | +9% | +5% | −3% | +14% | Concentrate strength; FX tailwind |
| EMEA | $2,823M | +18% | +7% | +6% | +17% | Broad-based acceleration |
| LatAm Foods | $1,934M | +16% | +3% | −2% | +7% | Resilient; pricing-led |
| Asia Pacific Foods | $1,139M | +11% | +7% | +10% | +30% | Fastest grower; volume-led |
| Total | $19,443M | +9%* | +3%* | +4% units | +5% | Organic accelerating |
*Total reported/organic rounding per company disclosure; consolidated organic revenue growth is +2.6%. Volume column reflects the company's segment volume measures (convenient foods units / beverage measures); consolidated organic-volume contribution to net revenue was a slight positive.
PFNA (Frito-Lay North America) — The Inflection, in the Flesh
This is the segment the entire coverage arc turned on, and it printed the number we required. Volume grew 2% and unit growth was 4%, adding "300 million new occasions" versus Q1 2025 — a sharp reversal from the −1% volume of Q4 and the −4% trough of Q3 2025. Organic revenue grew +1% (volume +2%, effective net pricing −1% as the affordability investments lower the price line), and reported revenue grew +2% to $6,332M. The cost of running this turn shows up in the profit line: core constant-currency operating profit fell −5%, partly because the prior-year quarter carried a property-sale gain and partly because the segment is funding value, advertising, and innovation. Management was explicit that the turn is multi-faceted — "more value in some of the core brands, multipacks and multiserve... a restage of some of the key brands like Lay's and Tostitos... a lot of innovation to accelerate our permissible and functional [portfolio]" — and that the structural execution (shelf resets, innovation ACV ramp) is only ~50% complete, with the balance landing into Q2 and the summer.
"When you see the 2% volume growth, it's a combination of all these elements... we increased 300 million occasions in Q1 in the food business... we're back to gaining share in the last 3 weeks. Not only in volume, we've had for quite some periods already, but now we have positive share in value as well... And actually, the cost for North America Foods went down in Q1, which is a remarkable achievement by the team." — Ramon Laguarta, Chairman & CEO
Assessment: This is the thesis-resolving disclosure. Positive volume and a return to value-share gains, with segment cost down, validates that the holistic commercial plan (not just price) is working. The −5% core c.c. operating-profit decline is the deliberate cost of the turn and is the right trade-off at this stage — management is reinvesting the productivity savings into the volume recovery. The one thing the bears will (correctly) flag: organic revenue at PFNA is still only +1%, and Lay's volume, while now growing, remains the hardest mainstream battle. We need PFNA organic revenue to follow volume higher through the year, with operating profit returning to growth by H2, to keep the segment on the upgrade trajectory.
PBNA (PepsiCo Beverages North America) — 9% Headline, Better Underneath
PBNA grew reported revenue +9% to $6,391M — but the headline mixes organic (+2%) with +7 points of inorganic contribution from acquired and distributed platforms (poppi, expanded energy distribution including CELSIUS). The segment's reported volume of −4% is distorted by the case-pack water transition to a third-party distributor; management said that ex-water, volume is "actually almost flat," with one more month of the transition to lap. Core constant-currency operating profit grew +7% — the profit re-expansion that began in Q4 (where it jumped 33% off an easy base) continued. Management framed the beverage portfolio as participating across the fastest-growing LRB segments: functional hydration (Gatorade/Propel) growing ahead of LRB for the first time in years, CELSIUS gaining energy share, modern soda (poppi) accelerating, and Mountain Dew innovation (Baja, "Dirty Dew" flavors) re-igniting the brand.
"If you excluded that [water] transition, the volume is actually almost flat. And we expect that acceleration will continue in the coming periods... the business grew 9% — a combination of organic growth, revenue growth of 2 plus 7 points of additional platforms that are now in our distribution system." — Ramon Laguarta, Chairman & CEO
Assessment: Beverages remains the segment that turned first and is now compounding. The +7% core c.c. profit growth on +2% organic is healthy operating leverage. The watch item is value share, which a pointed Q&A exchange surfaced is likely still in decline — the 9% top line is partly bought with acquired distribution rather than won organically. But the underlying volume trajectory (flat ex-water, improving) and the profit re-expansion are both moving the right way. Net positive.
International (IB Franchise, EMEA, LatAm Foods, Asia Pacific Foods) — The Durable Engine Re-Accelerates
Every international segment posted a sequential acceleration in net-revenue growth. EMEA grew reported +18% (organic +7%, volume +6%) with core c.c. operating profit +17%. Asia Pacific Foods was the standout — reported +11%, organic +7%, volume +10%, and core c.c. operating profit +30%. IB Franchise grew organic +5% (core c.c. OP +14%), and LatAm Foods stayed resilient at organic +3% (core c.c. OP +7%) despite a −2% volume reading on pricing-led growth in inflationary markets. Critically, management reported no demand impact from the Iran conflict and is leaning into a heavy summer commercial agenda anchored by the World Cup.
"The international business is very strategic to our long-term growth strategy... It's been accelerating. And actually, to your question, it continues to accelerate. So we haven't seen an impact on demand since the war started... The World Cup is a big driver of execution and innovation during the summer." — Ramon Laguarta, Chairman & CEO
Assessment: International is doing exactly what the thesis needs it to — growing mid-single-digit organic with strong operating leverage and a widening FX tailwind, while North America heals. The +30% APAC profit growth and +17% EMEA profit growth are the highest-leverage lines in the quarter. The geopolitical resilience claim is credible given PepsiCo's supply-chain redundancy, but it is the live risk to monitor: an escalation that hits either demand or input costs in EMEA/MEA would be the most plausible source of a guide-down later in the year.
Key Topics & Management Commentary
Overall Management Tone: Confident and execution-focused, but more measured than the Q4 victory-lap call — management is leaning into "we're in the middle of this reset, ahead of where we thought, and there's more to come" rather than declaring the turnaround complete. The CEO carried the call, repeatedly anchoring to operating proof points (300 million incremental occasions, value-share gains in the last three weeks, segment cost down) rather than financial targets, and the CFO was deliberate about preserving "as much flexibility as possible within the segments to hit our guidance" — a defensive posture on the building cost inflation from the Iran conflict. The single new note versus Q4 is the explicit acknowledgment of incremental cost pressure, met immediately with the three-lever inflation playbook (grow through it, push productivity, use price-pack architecture) — a confident answer, but the first time this arc that management has had to actively defend cost visibility rather than simply harvest a tailwind.
1. The PFNA Volume Inflection — Sustainability and Pull-Forward Risk
The dominant topic of the call, raised by nearly every analyst. The question behind the question was whether the +2% volume is durable or a one-time artifact of shipping ahead of shelf resets and winter-storm restocking. Management's answer leaned hard on repeat behavior and structural drivers: household penetration gains across all core brands, value-share gains (now in value terms, not just volume), and 300 million incremental occasions.
"This was a holistic commercial study focused on growth. There was some additional value to the consumer. There was more space. There was a restage of some of the key brands like Lay's and Tostitos. There was a lot of innovation to accelerate our permissible and functional. And there was a repurpose of funds towards away from home... All of that is delivering for us." — Ramon Laguarta, Chairman & CEO
Assessment: Management addressed the pull-forward concern directly and credibly — value-share gains and household-penetration gains are not explained by inventory timing. But the honest read is that the proof is still incomplete: the reset execution is ~50% done, and the durability verdict belongs to Q2–Q3 when the shelf resets fully lap and the innovation ACV matures. This is confirmation, not a closed case.
2. Margin Management — Funding the Turn Without Breaking the Operating Line
The central question for the thesis: can PepsiCo invest in PFNA affordability and innovation without the segment and total-company margins breaking? Q1 answers in the affirmative at the total-company level (+10bp core OM) while the CFO was explicit that PFNA margin would be managed within the broader portfolio, not protected in isolation.
"For PFNA specifically, we're going to continue to play offense. We're investing in value. We have exciting innovation... We'll manage margin as a total company, but we want to give ourselves as much flexibility as possible within the segments to do what's necessary to hit our guidance overall." — Steve Schmitt, CFO
Assessment: This is the right framing and the Q4 downgrade trigger ("first-half PFNA margin compresses >100bp on pricing without volume response") did not trip — PFNA's price line is down only ~1pt and volume responded. But "manage margin as a total company" is also management buying itself room: it implicitly concedes PFNA segment margin will be pressured in H1 and that the total-company guide depends on International and productivity offsetting it. Acceptable, and consistent with the plan — but it puts more weight on International durability and productivity delivery than a fully self-funding PFNA recovery would.
3. Productivity — The "Record Year" Engine Behind the Whole Story
Management characterized 2026 as on track for a record productivity year, and was explicit that productivity is what funds the offense in Foods. The buckets: prior-year headcount reductions, plant closures, and SKU rationalization now annualizing; improving supply-chain metrics (cases per hour); global shared services; and a widening AI/technology deployment across the supply chain and go-to-market (route optimization, digital ordering).
"We're benefiting from some of the moves from last year, the reduced headcount, plant closures, reduction in SKU count. It's encouraging to see key metrics like cases per hour and our supply chain continue to improve... we have more work to do on the total company cost structure... it's a big part of our strategy to make sure we continue to play offense." — Steve Schmitt, CFO
Management also surfaced a new structural lever: a vertical-integration test of the U.S. supply chain ("we're live in some tests in Texas... going to deploy that in some other states"), framed as a multi-year cost-transformation vector to be sized later in the year.
Assessment: Productivity is the load-bearing wall of the entire bull case — it is what allows PepsiCo to invest in price at the gross line and still expand operating margin. Q1's +10bp core OM expansion despite a 60bp gross-margin give-back is the evidence it's working. The risk is finiteness: productivity is a depletable resource, and the more it funds the Foods turn, the less cushion exists if cost inflation accelerates. The Texas vertical-integration test is genuine optionality but unsized.
4. Building Cost Inflation — The New Variable from the Iran Conflict
The first question on the call was about the cost impact of the Iran conflict, and it framed the new uncertainty in the FY guide. Management's posture: 6–12-month systemic hedges give near-term visibility, inflation "will come" but the magnitude is undetermined, and the three-lever playbook (grow through it, productivity, price-pack architecture) will absorb it. Crucially, management said the FY26 guide already reflects the assumption that they can mitigate what comes this year.
"Our assumption is that inflation will come. The order of magnitude, we're still working through... The way I think about managing inflation would be 3 ways over time. One, you grow your way through it... The second is you push harder on productivity. And third, you do have options with your price pack architecture. We'd like to do the majority of it through the first 2." — Steve Schmitt, CFO
Assessment: This is the most important new risk in the report. The FY guide being affirmed (not raised) despite an organic-revenue beat and a widening FX tailwind is, in part, management quietly building a cost-inflation cushion into the back half. The hedge book covers near-term; the open question is 2027, which management explicitly declined to address ("we've started to begin our work on 2027 scenarios... we don't have anything more to share"). Watch H2 gross margin: if cost inflation outruns the hedge book and productivity, the affordability-investment runway narrows precisely when the Foods turn most needs it.
5. International Acceleration and Geopolitical Resilience
International is the durable engine, and management leaned into the World Cup as a summer activation catalyst across both food (Lay's "No Lay's No Game," Quaker, flavors-from-around-the-world innovation) and the broader portfolio. The geopolitical message was reassuring: no demand impact from the conflict, supply-chain redundancy built post-COVID providing an advantage versus competitors, and in some markets a relative share benefit from superior supply continuity.
"In some markets, we're seeing benefit because we have better supply chain than some of our competitors, especially in the food business. So nothing remarkable at this point... in our guidance, we haven't assumed any impact because we're not seeing any at this point." — Ramon Laguarta, Chairman & CEO
Assessment: The international acceleration is real and the highest-leverage part of the quarter (+17% EMEA / +30% APAC profit). But "we haven't assumed any [conflict] impact in guidance" is a double-edged disclosure: it means the guide has no buffer for a demand or cost shock in the most-exposed region. The resilience is credible today; it is also the most plausible single source of a negative surprise later in the year.
6. Elliott, Portfolio Reshaping, and PBNA Refranchising
The Q3 thesis introduced Elliott Management's ~$4B activist stake as a value-unlock catalyst, and Q4 noted "small refranchising models" being studied. Q1 advanced the structural-review theme modestly: a Q&A exchange on PBNA value share explicitly tied market-share improvement to the strategic review and "the bottler network," and management's vertical-integration test in Texas reads as part of the same portfolio-and-distribution optimization. But no concrete refranchising commitment or published Frito-Lay margin target was disclosed.
"PBNA is growing 9% total business... we see ourselves participating in the energy portfolio through our CELSIUS investment... We still have some work to do on accelerating the coffee business and accelerating the tea business." — Ramon Laguarta, Chairman & CEO
Assessment: Elliott optionality remains latent — advancing through the distribution/vertical-integration tests but not yet crystallized into a quantified value-unlock event. For the thesis, this is a free option to the upside: the Outperform does not depend on it, but a concrete refranchising or margin-target announcement later in 2026 would be a discrete catalyst. We are not paying for it at $158.
7. SNAP Cuts and GLP-1 — The Slow-Burn Demand Risks
Two structural demand questions were addressed briefly. On SNAP restrictions (8 states began restricting purchases in Q1, mainly beverages and candy), management said it's "too early to come to any definitive conclusions." On GLP-1, management did not dwell — the answer pivoted to the snacks category accelerating and PepsiCo gaining share, with the permissible/functional portfolio (SunChips, Smartfood, no-artificial Gatorade) as the adaptation strategy.
"We did have 8 states that began restriction in the first quarter. It's mainly beverages and candy. I think it's too early to come to any definitive conclusions right now in terms of impact... the LRB category overall remains robust." — Steve Schmitt, CFO
Assessment: Both are real, slow-burn risks rather than Q1 events. SNAP is a measurable 2026–2027 watch item concentrated in beverages/candy; GLP-1 is the longer-tail structural overhang on the entire salty-snack and sugary-beverage complex. Management's portfolio-adaptation answer is reasonable but not a resolution. Neither moves the near-term thesis; both cap the long-term multiple.
Guidance & Outlook
| FY2026 Metric | Prior Guide (Q4 2025) | New Guide (Q1 2026) | Change |
|---|---|---|---|
| Organic revenue growth | +2 to +4% | +2 to +4% | Affirmed |
| Core constant-currency EPS growth | +4 to +6% | +4 to +6% | Affirmed |
| Core effective tax rate | ~22% | ~22% | Affirmed |
| Capital spending | <5% of net revenue | <5% of net revenue | Affirmed |
| FCF conversion | ≥80% | ≥80% | Affirmed |
| Total cash returns | ~$8.9B ($7.9B div + $1.0B buyback) | ~$8.9B ($7.9B div + $1.0B buyback) | Affirmed |
| FX translation impact | ~+1pt tailwind | ~+1pt tailwind | Affirmed |
| M&A (net) contribution | ~+1pt to reported revenue | ~+1pt to reported revenue | Affirmed |
| Implied reported revenue growth | +4 to +6% | +4 to +6% | Affirmed |
| Implied core EPS growth (reported) | ~+5 to +7% | ~+5 to +7% | Affirmed |
| Annualized dividend per share | $5.92 (+4%, 54th yr) | $5.92 (+4%, begins June 2026) | On track |
The headline guidance act is that nothing changed: FY2026 was affirmed across every line. Management framed the year as balanced between first and second half, with organic revenue trending toward the upper end of the +2–4% range in the back half as North America Foods and International continue to progress and the shelf-reset/innovation execution fully lands. The dividend increase to $5.92 (the 54th consecutive annual raise) begins with the June 2026 payment.
The signal in an affirm-not-raise: PepsiCo beat organic revenue (+2.6% vs. the ~+1.7–2% the Street modeled), beat core EPS by $0.06, is carrying a widening FX tailwind (+3.4pt revenue / +4pt OP this quarter versus the ~+1pt assumed for the year), and turned PFNA volume positive — yet did not raise the full-year guide. The most probable reason is the building cost inflation from the Iran conflict, which management is absorbing into the back-half assumption rather than letting flow through to a raise. That is prudent and consistent with the CFO's "give ourselves flexibility" posture, but it also means the easy beat-and-raise that a clean Q1 might have produced was deliberately withheld — and that the H2 setup now carries an undisclosed cost-inflation assumption.
Implied H2 ramp: Q1 organic was +2.6%; to land the back half toward the +4% upper end, organic must accelerate roughly a point as the reset execution completes and the World Cup activation lands. Street at: consensus sits near the middle of the +2–4% organic / +4–6% core c.c. EPS guide; the Q1 beat does not yet move full-year consensus materially because the guide was affirmed. Guidance style: conservative-to-realistic — consistent with PepsiCo's pattern of guiding to a deliverable range and letting FX/productivity provide upside, with the new wrinkle that the cost-inflation cushion is now the offsetting drag.
Analyst Q&A Highlights
Iran Conflict: Cost Visibility and FY Earnings Confidence
The opening exchange tested whether the building cost pressure and external volatility threaten full-year earnings visibility, and what internal offsets exist. Management's answer leaned on hedge coverage and the three-lever inflation playbook, and asserted the FY guide already reflects an assumption of mitigation.
Q: "Can you highlight what's changed in terms of your cost assumptions?... I'm presuming costs have gone up. So what are the offsets internally as you think about 2026 earnings visibility? And do you think you still have that visibility even with the external volatility?"
— Dara Mohsenian, Morgan Stanley
A: "We've had no major issues from a supply chain standpoint... We typically have about 6- to 12-month hedges in place... Our assumption is that inflation will come. The order of magnitude, we're still working through... From a visibility and guidance standpoint, our assumption is that we can mitigate what comes our way this year, and that's really reflected in our assumptions on guidance."
— Steve Schmitt, CFO
Assessment: Management answered with confidence on near-term visibility (hedges) and committed that the guide bakes in mitigation — but conspicuously declined to size the inflation or address 2027. The honest read is that the FY affirm rather than raise is, in part, the cost-inflation cushion. This was the most important exchange on the call for the H2 setup.
PFNA Volume: Durability vs. Pull-Forward
The first of many PFNA questions probed whether the volume inflection was structural or aided by shipping ahead of shelf resets and winter restocking, and whether repeat-purchase rates support the order refills. Management cited value-share gains, household penetration, and incremental occasions as evidence the turn is consumer-driven, not timing-driven.
Q: "Congrats on the volume inflection. How sustainable do you see this performance if... some investors may have asked if you had some benefit from shipping ahead of the shelf resets and then the winter storms? And how has the repeat rates been in your view for the refilling of those orders?"
— Andrea Teixeira, JPMorgan
A: "We grew 300 million occasions in Q1 in the food business... we got positive share. Not only in volume, we've had for quite some periods already, but now we have positive share in value as well, which is one of the KPIs that we set for ourselves early on... feeling very good about how the brands are reacting."
— Ramon Laguarta, Chairman & CEO
Assessment: A substantive, non-defensive answer that addressed the pull-forward concern with the right metrics — value-share and penetration gains are not timing artifacts. But management conceded the reset is only ~50% complete, so the durability verdict is genuinely a Q2–Q3 question. Confirmation, not closure.
PFNA Margin and PBNA Volume Trajectory
A two-part question sought confirmation that PFNA would deliver both organic growth and margin expansion this year, and pressed on what is pressuring PBNA volume and whether beverage declines moderate going forward. Management deflected the PFNA-margin guarantee toward total-company flexibility and attributed PBNA volume to the lapping water transition.
Q: "I just wanted to verify that you still expect to deliver both organic revenue growth and core operating margin expansion this year for [PFNA]... should we assume PBNA volumes will be negative this year, but declines will moderate and improve for the next few quarters?"
— Bonnie Herzog, Goldman Sachs
A: "We affirmed our guidance today. We'll manage margin as a total company, but we want to give ourselves as much flexibility as possible within the segments... If you excluded that [water] transition, the [PBNA] volume is actually almost flat. And we expect that acceleration will continue."
— Steve Schmitt, CFO / Ramon Laguarta, Chairman & CEO
Assessment: The notable tell: management would not commit to PFNA segment margin expansion this year, redirecting to total-company flexibility. That is an implicit concession that PFNA margin will be pressured in H1 and that the guide leans on International and productivity offsets. On PBNA, the ex-water flat-volume framing is credible and the lap is nearly done.
Lay's Specifically: Furthest Along, Still Soft
A granular push on Lay's — the brand PepsiCo moved on earliest (Super Bowl ad, simpler-ingredients repositioning, price adjustments) but where scanner data still looked weak. Management argued the global Lay's restage is performing and that the brand grew volume in the quarter, reframing the question around the broader PFNA success metrics.
Q: "That [Lay's] business... still looks pretty weak in aggregate, volumes bumpy, but still generally down and organic down pretty significantly. I would think that's the business that's the toughest in terms of mainstream competition and less differentiation... maybe your perspective on what I might be missing."
— Lauren Lieberman, Barclays
A: "The Lay's brand is part of a more holistic restage of the full business... It is performing well in the U.S. We grew volume this quarter in Lay's in particular... In IRI, we're gaining share in value terms in the last few weeks, and we've been gaining volume share now for 3 or 4 periods."
— Ramon Laguarta, Chairman & CEO
Assessment: Management claimed Lay's grew volume and is gaining share, but reframed away from the analyst's point that aggregate Lay's organic is still down meaningfully. The data dispute (IRI vs. Nielsen) is real — PepsiCo uses IRI internally and reports value-share gains there. The honest synthesis: Lay's is improving but remains the hardest, lowest-differentiation battle in the portfolio, and the turn is earliest-and-thinnest there.
Innovation and Distribution Cadence into Q2
A question on the relative contribution of distribution gains versus innovation into Q2, given a heavy product-launch slate (protein, fiber, Smartfood). Management quantified the runway: innovation is at ~40–50% ACV and planogram resets ~50% complete, implying acceleration through the summer.
Q: "How should we think about the relative size of distribution gains and the contribution from innovation in Q2 versus Q1? You have a lot of products shipping in Q2... should we see an acceleration into late April and May?"
— Filippo Falorni, Citi
A: "The majority of our innovation is, let's say, 40%, 50% ACV at this point. So we should expect that we accelerate that in the balance of the quarter and into the summer. The same with the planogram resets — we're probably 50% more or less in the process of transformation of the space for the year."
— Ramon Laguarta, Chairman & CEO
Assessment: This is the most useful forward data point on the call — it quantifies the runway. With innovation at half its eventual ACV and resets half-done, the structural drivers of the volume turn are only partway loaded, which supports the sequential-acceleration thesis into H2. It also means H1 is the show-me period; the real test of durability is the fully-loaded Q3.
Productivity: The Buckets and the Scaling
A question on the productivity program — what is different this year, the major buckets, and how it scales through 2026 into 2027. Management detailed last-year carryover (headcount, plant closures, SKU reduction), improving supply-chain metrics, and a widening AI/technology and global-shared-services push, plus the new U.S. vertical-integration test.
Q: "Can you talk about the major buckets for productivity, what you're doing maybe differently this year than in prior years... And then how you see that productivity gain scaling up through this year and into next year?"
— Robert Ottenstein, Evercore
A: "We're benefiting from some of the moves from last year — the reduced headcount, plant closures, reduction in SKU count... we're leveraging technology and AI and data to drive efficiency... we're live in some tests in Texas [on supply-chain integration], and we're going to deploy that in some other states."
— Steve Schmitt, CFO / Ramon Laguarta, Chairman & CEO
Assessment: Productivity is the engine that makes the whole bull case internally consistent — it funds the price investment and still expands operating margin. The Q1 proof (+10bp core OM on a 60bp gross-margin give-back) is the evidence. The Texas vertical-integration test is genuine multi-year optionality, unsized today. The watch is finiteness: the more productivity funds the Foods turn, the thinner the cushion against accelerating cost inflation.
Quality of the Incremental Volume — Who Are the New Occasions?
A question probing the "300 million incremental occasions" figure — who these consumers are, and whether the growth is core or incremental. Management split it into two sources: lapsed consumers returning to the core via better multipack/multiserve value, and net-new consumers entering the category via no-artificial/permissible innovation. This matters because incremental occasions, not just price-driven repeat purchases, are what make a volume turn structural.
Q: "You had mentioned the very substantial increase in the number of occasions. Can you maybe dig into that a little bit more? Who are these consumers? Or what are those occasions? Are they different from the core?"
— Kaumil Gajrawala, Jefferies
A: "By optimizing the value in some of our multi-serve and multipacks... we are bringing lapsed consumers into the brand. So these are consumers that had left the brand... that is growth in the core. At the same time... consumers that were not in the category, but because they love our flavor[s]... we're offering solutions with no colors, no artificial colors, no artificial flavors and they're coming back to the category."
— Ramon Laguarta, Chairman & CEO
Assessment: This is the right decomposition for judging durability — lapsed-consumer reactivation (core) plus net-new category entrants (innovation-led incrementality). Both are structural rather than promotional, which supports the turn being more than a price-pulse. The caveat is that this is management's qualitative framing; the durability proof is still the repeat-rate and household-penetration data over the next two quarters.
What They're NOT Saying
- The magnitude of cost inflation: Management repeatedly said "inflation will come" but explicitly declined to size it ("the order of magnitude, we're still working through"). Affirming — not raising — the FY guide after an organic-revenue and EPS beat is the tell: an undisclosed cost cushion is being built into the back half.
- Any 2027 framing: The CFO said they've "started to begin our work on 2027 scenarios" but "don't have anything more to share." For a company whose hedge book only covers 6–12 months, the silence on 2027 cost exposure is the most conspicuous omission — it means the multi-year inflation question is open.
- A PFNA segment margin commitment: Asked directly whether PFNA would deliver both organic growth and margin expansion this year, management redirected to "manage margin as a total company." The refusal to commit at the segment level is an implicit concession that PFNA margin is pressured in H1.
- PBNA value share: A pointed question established that PBNA value share is likely still in decline; management pivoted to the 9% reported growth (which is partly acquired distribution) and energy/functional-hydration wins, without directly confirming or denying the organic value-share trajectory.
- A quantified Elliott/refranchising outcome: The structural review surfaced only obliquely (vertical-integration tests, "small refranchising models" from Q4 not advanced). No published Frito-Lay margin target, no refranchising commitment, no timeline — the value-unlock catalyst remains latent.
- Lay's aggregate organic revenue: Management claimed Lay's grew volume and gained share but never confirmed or denied the analyst's assertion that aggregate Lay's organic is still down meaningfully — the reframing toward unit/occasion metrics sidestepped the dollar-revenue question on the hardest brand.
- Quantified SNAP and GLP-1 impact: Both demand risks were acknowledged and then minimized as "too early" / addressed via portfolio adaptation. No sizing of the SNAP-restriction drag (8 states, beverages/candy) and no framework for GLP-1's category impact — the slow-burn risks were noted, not quantified.
Market Reaction
- Pre-print setup: PEP closed at $154.85 on April 15, the day before the before-the-open print. Entering the quarter, the stock was +7.9% YTD (from $143.52 at 2025 year-end), +10.5% over the trailing twelve months (from $140.09), and −1.1% over the trailing 30 days — the de-rating that defined the washed-out July 2025 entry has fully reversed, with the 52-week closing range at $128.02–$170.49. The S&P 500 was +2.6% YTD into the print, so PEP had outpaced the index by ~5 points YTD.
- Reaction (same-day, BMO): The stock gapped +0.4% at the open ($155.54), traded an intraday range of $154.26–$159.79, and closed at $158.38, up +2.3% (+$3.53) on 10.4M shares versus a 6.1M 30-day average (1.7x volume). The S&P 500 was +0.3% on the session, so PEP outperformed the tape by ~2 points on the day.
The +2.3% reaction was positive but muted — roughly half the +4.9% Q4 print response, on a quarter that delivered the single most important thesis confirmation of the entire arc (positive Foods volume). That gap is the most important signal in the market reaction: good news is increasingly in the stock. After a +10.5% trailing-twelve-month run that fully reversed the de-rating, the volume turn was substantially anticipated, and a clean-but-affirm-not-raise quarter cleared the bar without re-rating the multiple. The 1.7x volume confirms genuine engagement (not a quiet drift), and the close near the intraday high signals buyers carried the session — but the magnitude tells you the easy money in the recovery trade has been made. This is a "confirmation rally," not a "discovery rally."
Street Perspective
Debate: Is the Frito-Lay Volume Turn Durable or a Reset-Timing Head-Fake?
Bull view: +2% volume, +4% units, 300 million incremental occasions, household-penetration gains across all core brands, and a return to value-share gains are consumer-driven signals that cannot be explained by inventory timing. With shelf resets and innovation ACV only ~50% loaded, the structural drivers accelerate through H2 — this is the early innings of a multi-quarter recovery.
Bear view: Q1 benefited from shipping ahead of shelf resets and winter restocking; PFNA organic revenue is still only +1% and the price line is down, so the volume is partly bought; Lay's aggregate organic remains soft; and the durability verdict belongs to Q3 when the resets fully lap. One good volume quarter does not make a turn.
Our take: Bull, with discipline. The value-share and penetration data are the tell — they are not timing artifacts, and management addressed the pull-forward question credibly. But the bears are right that the proof is incomplete: PFNA organic revenue and operating profit both need to follow volume higher by H2. We treat the turn as confirmed-but-not-closed; the Q3 print (fully-loaded resets) is the decisive test.
Debate: Does the FY Affirm (Not Raise) Signal Caution or Conservatism?
Bull view: Affirming after a Q1 beat is classic PepsiCo conservatism — the company guides to a deliverable range and lets FX/productivity provide the upside through the year. With organic accelerating, FX a tailwind, and the back half setting up for the upper end of the range, the affirm is a floor, not a ceiling, and a beat-and-raise likely comes mid-year.
Bear view: A clean Q1 beat with a widening FX tailwind that does not produce a raise is a quiet warning — management is absorbing building cost inflation (Iran conflict) into the back half and refused to size it or address 2027. The cushion that should have flowed to a raise is being held against an undisclosed cost risk; the guide could just as easily be at risk later in the year.
Our take: Partial bull. The affirm is mostly conservatism, but the bears identify the right specific risk: the cost-inflation cushion is real and the H2 guide now carries an undisclosed assumption. We do not expect a guide cut, but we no longer expect the easy beat-and-raise either — H2 gross margin is the line to watch.
Debate: Valuation — Is There Still Asymmetry at $158?
Bull view: At ~$158 and ~$8.20–8.35 of FY26 core EPS, PEP trades at ~19x forward for a confirmed return to mid-single-digit organic and +4–6% core EPS growth, a 3.7% dividend yield with a 54-year raise streak, a widening FX tailwind, record-productivity funding, and a live Elliott value-unlock option. That is a reasonable multiple for a re-accelerating quality staple, and the multiple can re-rate toward 21–22x as the turn proves durable.
Bear view: The stock has already re-rated — +10.5% TTM, fully recovered from the washed-out low, with the easy money made. At 19x for a +4–6% EPS grower facing GLP-1 and SNAP structural overhangs, building cost inflation, and a turn that is only half-proven, the risk/reward is now market-like at best. The muted +2.3% reaction is the market telling you the recovery is priced.
Our take: The bears are directionally right that the asymmetry has compressed materially since the July 2025 entry — this is no longer cheap-and-hated. But 19x for a confirmed re-acceleration with a 3.7% yield, FX tailwind, productivity runway, and Elliott optionality still screens favorably against the S&P on a 12-month total-return basis. The Outperform survives, but it now rests on execution and the dividend/total-return floor, not on a trough-multiple re-rating. We model a more measured upside than the Q4 upgrade implied.
Model Update & Valuation Framework
| Item | Prior Model (Q4 2025 Recap) | Updated Model (Q1 2026 Recap) | Reason |
|---|---|---|---|
| FY26 organic revenue growth | +2 to +4% | +2.5 to +4% (lean upper-mid) | Q1 organic +2.6% accelerating; resets/innovation H2-loaded |
| FY26 core c.c. EPS growth | +4 to +6% | +4 to +6% (mid) | Guide affirmed; cost-inflation cushion offsets FX/organic upside |
| FY26 core EPS (reported) | ~$8.15–8.35 | ~$8.20–8.40 | FX tailwind widened (+3.4pt rev / +4pt OP in Q1) |
| FY26 reported revenue growth | +4 to +6% | +5 to +6% | Wider FX tailwind + M&A; Q1 reported +8.5% |
| FY26 core operating margin | Modest expansion | Flat-to-modest expansion | +10bp Q1; PFNA margin pressured H1, productivity/Intl offset |
| FY26 FX impact | ~+1pt tailwind | ~+1 to +2pt tailwind | Q1 ran +3.4pt rev; full-year tailwind tracking above guide |
| FY26 cost inflation | Not a factor | New back-half assumption | Iran conflict; hedges cover near-term; magnitude undisclosed |
| 12-month PT (base case) | ~$165 (~19x; +7% from breakout) | ~$172 (21x × ~$8.20 FY26 core EPS) | Turn confirmed; modest re-rate as durability proves |
| 12-month PT (bull case) | ~$180 | ~$188 (22.5x × ~$8.35) | H2 acceleration + Elliott catalyst + sustained FX tailwind |
| 12-month PT (bear case) | ~$140 | ~$140 (17x × ~$8.20) | PFNA turn fades / cost inflation outruns hedges / guide trim |
Valuation framework: At the $158.38 post-print price and ~$8.20 of FY26 core EPS, PEP trades at ~19.3x forward earnings with a 3.7% dividend yield. Our base-case PT of ~$172 applies a 21x multiple to the lower-end of our FY26 core-EPS range, implying ~+9% price upside plus the ~3.7% yield for a ~13% total return — ahead of our S&P 500 12-month expectation, which is the Outperform threshold. The bull case (~$188, +19% + yield) requires H2 organic acceleration toward the +4% upper end and a concrete Elliott/refranchising catalyst; the bear case (~$140, −12% but cushioned by the yield) requires the PFNA turn to fade or cost inflation to outrun the hedge book into a back-half guide trim.
Revised risk-reward: The asymmetry has compressed materially since the July 2025 initiation. At the washed-out $135–145 entry, the upside-to-downside was roughly 2.5:1 on a re-rating off a trough multiple. At $158 post-confirmation, it is closer to 1.3–1.5:1 — still favorable for Outperform, but now anchored by the total-return floor (yield + modest re-rate as the turn proves durable) rather than by deep-value optionality. The Outperform call is now an execution bet, not a re-rating bet.
Thesis Scorecard: The Q4 2025 Signposts Revisited
The Q4 2025 upgrade named precise Q1 2026 signposts and two downgrade triggers (back to Hold; to Underperform). Q1 cleanly satisfies the bullish signposts and trips none of the downgrade triggers.
| Q4 Signpost | Bullish if… | Q1 2026 Actual | Verdict |
|---|---|---|---|
| PFNA volume | Volume flat or positive | Volume +2%, units +4%, 300M incremental occasions | Strongly Bullish |
| PFNA margin | Margin flat-to-up despite price investments | Segment core c.c. OP −5% (invested); total-co core OM +10bp | Mixed (total-co held) |
| Shelf-space gains | Confirmed in-store; converting to volume | Resets ~50% complete; gains "as expected"; converting to volume + value share | Bullish |
| PBNA volume | Volume decline narrows toward flat | Reported −4%, ~flat ex-water transition; one month left to lap | Bullish (underneath) |
| Organic revenue | ≥+2% with NA-led mix | +2.6%, accelerating from Q4; NA healing + International leading | Bullish |
| FY2026 guide | Maintained or raised | Affirmed (+2–4% organic / +4–6% core c.c. EPS) | Met |
| Distribution / refranchising | Concrete refranchising / margin-target signal | Vertical-integration test (Texas); no published target or commitment | Partial |
| Brand restages | Early restage data shows volume/share gains | Lay's/Tostitos restaged; volume + value-share gains; Quaker/Gatorade later | Bullish |
| Productivity savings | On-track; funding reinvestment with net margin expansion | "Record year" on track; +10bp core OM on 60bp gross give-back; NA Foods cost down | Bullish |
Scorecard summary: 7 of 9 signposts tripped bullish, 2 mixed/partial (PFNA segment margin invested rather than expanded; refranchising still latent), 0 bearish. The decisive signpost — PFNA volume turning positive — tripped strongly bullish. The two non-clean reads are both deliberate-and-acceptable: PFNA segment margin was invested by design (and the total-company operating margin still expanded), and the refranchising catalyst remains a free option. Most importantly, neither downgrade trigger fired: PFNA volume turned positive rather than slipping below −2%, and total-company core operating margin expanded rather than compressing >100bp on pricing.
Full Bull / Bear Matrix: Updated Through Q1 2026
| Thesis Point | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Current Verdict |
|---|---|---|---|---|---|
| Bull #1: Washed-out staple bottoming on a re-acceleration plan | Neutral | Confirmed | Strengthened | Confirmed (priced) | Organic accelerating to +2.6%; but +10.5% TTM means the de-rating recovery is done |
| Bull #2: NA Beverages turns before Foods | Early | Confirmed | Strongly confirmed | Compounding | PBNA +7% core c.c. OP; ~flat volume ex-water; profit re-expansion sustained |
| Bull #3: NA Foods (Frito-Lay) volume stabilizes and re-accelerates | Challenged | Challenged (vol −4%) | Confirmed (turn arrived) | Inflected positive | Volume +2%, units +4%; the thesis-resolving print — but organic rev still only +1% |
| Bull #4: Explicit cost program funds reinvestment with margin expansion | — | Introduced | Strongly confirmed | Confirmed (modest) | +10bp core OM on 60bp gross give-back; NA Foods cost down — engine works, leverage thinner than Q4 |
| Bull #5: International resilient and accretive | Confirmed | Confirmed | Confirmed | Strengthened | Every Intl segment accelerated; EMEA +17% / APAC +30% core c.c. OP; no conflict demand impact |
| Bull #6: FX flips from headwind to tailwind | Headwind | Neutralizing | Confirmed tailwind | Widening tailwind | +3.4pt revenue / +4pt OP in Q1; running ahead of the ~+1pt FY assumption |
| Bull #7: Elliott activist value-unlock optionality | — | Introduced | Advancing (latent) | Advancing (latent) | Vertical-integration test in Texas; PBNA bottler-network review acknowledged; no quantified outcome |
| Bear #1: GLP-1 demand destruction | Active | Active | Active (addressed) | Active (minimized) | Portfolio adaptation (permissible/functional); category accelerating per mgmt; long-term unresolved |
| Bear #2: First-half affordability pricing breaks PFNA margin | — | — | Active (new) | Did not break (invested by design) | PFNA core c.c. OP −5% deliberate; total-co OM +10bp; the Q4 downgrade trigger did NOT trip |
| Bear #3: Growth leans on productivity/FX/M&A, not organic volume | Active | Active | Active (mild) | Weakened | Consolidated organic volume turned slightly positive for the first time — the strongest rebuttal yet |
| Bear #4 (NEW): Building cost inflation (Iran conflict) | — | — | — | Active (new, unsized) | Hedges cover 6–12 months; magnitude undisclosed; 2027 unaddressed; absorbed into H2 guide |
| Bear #5: Global minimum tax / below-the-line drag | — | — | Active (mild) | Active (mild) | Core ETR ticked to 21.1% (from 20.4%); net interest widened; external, transparent |
| Bear #6: Valuation limits upside post-breakout | — | Active (mild) | Active (moderate) | Active (moderate-to-elevated) | ~19x forward at $158; +10.5% TTM; muted +2.3% reaction confirms recovery is priced |
| Bear #7 (NEW): SNAP restrictions | — | — | — | Active (mild) | 8 states restricting (beverages/candy); "too early" to size; 2026–2027 watch item |
Overall matrix assessment: Seven bull points — six confirmed/strengthened (with the Frito-Lay volume inflection moving from "confirmed turn" to "inflected positive," and consolidated organic volume turning positive for the first time decisively weakening the "growth-isn't-organic" bear), one advancing-but-latent (Elliott). On the bear side, the Q4 marquee concern (affordability pricing breaking PFNA margin) did not materialize — it was invested by design and the total-company margin expanded — but two new bears appear: building cost inflation from the Iran conflict (unsized, the most important new risk) and SNAP restrictions. The valuation bear has escalated to moderate-to-elevated. Net, the operating thesis is confirmed and slightly stronger; the risk/reward is narrower because the price has caught up and a new cost-inflation overhang has emerged.
Bottom Line: The Confirmation, and the Compression
Rating decision: We maintain Outperform on PEP. We initiated at Hold (Q2 2025), held through Q3 (when Beverages turned but Foods volume got worse), and upgraded to Outperform at Q4 on the Frito-Lay volume bend toward flat plus proof the cost program funds growth without breaking margin. Q1 2026 confirms that upgrade on its own terms — and it does so by clearing the single variable the entire arc was gated on:
- PFNA volume inflected positive: +2% volume, +4% units, 300 million incremental occasions, value-share gains — the turn the Hold rating waited three quarters for. ✓
- Organic revenue accelerated: +2.6% (from ~+2.1% in Q4), with a slight positive consolidated organic-volume contribution for the first time. ✓
- Margin held: total-company core operating margin +10bp despite the affordability give-back at the gross line — the Q4 downgrade trigger did not trip. ✓
- International re-accelerated everywhere: EMEA +17% / APAC +30% core c.c. operating profit; no conflict demand impact. ✓
- FY2026 guide affirmed: +2–4% organic / +4–6% core c.c. EPS, with the 54th consecutive dividend raise on track. ✓
- Core EPS +9% (+5% c.c.): a clean, operating-and-FX-driven beat — solid, though below Q4's double-digit pace. ✓
But the honest part of this note is the compression. The reason this is a maintained Outperform with a measured tone rather than a celebratory one is that the easy money in PepsiCo has been made. We underwrote the upgrade at a washed-out valuation with a clear catalyst path; the catalyst has now substantially played out, the stock is +10.5% over twelve months and back near the top of its 52-week range, and the muted +2.3% reaction — half the Q4 response on the most important confirmation of the arc — is the market pricing the recovery. The Outperform no longer rests on a re-rating off a trough; it rests on continued execution: sustained PFNA volume as the resets fully load in H2, productivity continuing to fund the offense, International durability through a heavy summer, FX staying a tailwind, and Elliott optionality crystallizing into a catalyst. That is a thinner, execution-dependent edge than the deep-value setup we started with — but at ~19x with a 3.7% yield, a confirmed re-acceleration, and a widening FX tailwind, the 12-month total-return case still screens ahead of the S&P.
What would change our mind:
- Back to Hold: The PFNA volume turn fades as the resets fully lap (volume slips back below flat by Q3); OR back-half cost inflation outruns the hedge book and productivity, forcing a trim of the +4–6% core c.c. EPS guide; OR the risk/reward becomes plainly market-like — if the stock pushes toward the high end of its range ($168–170+) without a commensurate step-up in the durability evidence, the total-return edge over the S&P narrows to inline and we would step down to Hold on valuation-fullness.
- To Underperform: PFNA volume re-accelerates downward in H2 (the turn proves a head-fake); OR a genuine guide-down on cost inflation or an International demand shock; OR the productivity engine proves insufficient to fund reinvestment AND hold margin, breaking the internal consistency of the bull case.
Signposts for Q2 2026 earnings (July 2026):
| Signpost | What to Watch | Bullish if… | Bearish if… |
|---|---|---|---|
| PFNA volume | Follow-through with resets fully loading | Volume holds positive (+1% or better) | Volume slips back below flat |
| PFNA organic revenue | Revenue following volume higher | Organic rev accelerates above +1% (price line stabilizes) | Organic rev stays ~+1% or weaker on deeper price cuts |
| PFNA / total-company margin | Operating leverage as volume scales | PFNA core OP returns toward flat/growth; total OM expands | Margin compresses on deepening affordability investment |
| PBNA volume ex-water | First clean post-transition read | Volume flat-to-positive once water transition fully laps | Underlying volume stays negative ex-water |
| Organic revenue (total) | vs. +2–4% FY guide (H2-weighted) | ≥+3%, tracking toward upper end | Decelerates below +2% |
| FY2026 guide | +2–4% organic / +4–6% core c.c. EPS | Raised (FX/organic upside flows through) | Trimmed or H2 qualified on cost inflation |
| Cost inflation | The unsized Iran-conflict assumption | Management sizes it and it's contained within productivity/hedges | Inflation outruns hedge book; H2 gross margin pressured |
| Gross margin | The line carrying the affordability investment | Gross margin stabilizes / declines moderate | Gross margin compression deepens beyond Q1's 60bp |
| International | Durability through the World Cup summer | Mid-single-digit organic sustained; no conflict demand hit | EMEA/MEA demand or input-cost shock |
| Elliott / refranchising | The latent value-unlock catalyst | Concrete refranchising commitment or published Frito-Lay margin target | Indefinite deferral or walk-back of the structural review |
| SNAP impact | The 8-state restriction drag | Sized and immaterial | Measurable beverage/candy volume drag emerging |